Sun.Jun 09, 2024

article thumbnail

Don’t Forget to Address Autoimmune Comorbidities of Atopic Dermatitis

Dermatology Times

Jonathan Silverberg, MD, PhD, MPH, presented his tips for effectively treating atopic dermatitis without worsening autoimmune comorbidities.

article thumbnail

Zucchini and Quinoa Breakfast Bowl

Alison Bladh

Zucchini and Quinoa Breakfast Bowl Start your day with this Zucchini and Quinoa Breakfast Bowl, a delightful combination of wholesome quinoa and fresh zucchini. This nutrient-packed dish is perfect for a light yet satisfying breakfast. The added freshness from the herbs and the slight crunch of the veggies make it a perfect start to your morning. Ingredients: For the Breakfast Bowl: • 1 cup cooked quinoa (180 g / 6 oz) • 1 medium zucchini (about 200 g / 7 oz), spiralised or grated • 1/2 cup cher

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Considerations for Topical Therapeutics and Clinical Excellence in Vitiligo

Dermatology Times

Nanette Silverberg, MD, shares data on the efficacy of on- and off-label therapeutics for vitiligo, as well as the importance of communication with patients to promote clinical excellence.

Clinic 74
article thumbnail

Day 1 Recap: 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference

Dermatology Times

Catch up on coverage from the first day of the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference in Chicago, Illinois.

Eczema 72
Find a school
article thumbnail

Upadacitinib Demonstrates Continued Improvements in Patients With Moderate to Severe AD Through 140 Weeks

Dermatology Times

Improvements in patient-reported outcomes were higher among patients treated with upadacitinib 30mg versus 15mg.

74
article thumbnail

Spotlighting Vitiligo: New Innovations to be Presented at RAVE 2024

Dermatology Times

Nanette Silverberg, MD, shares her excitement about the inclusion of vitiligo at this year’s RAVE meeting.

More Trending

article thumbnail

Ritlecitinib Shows Promising Results in Long-Term Trial

Dermatology Times

Researchers found patients with less than 95% hair loss at baseline reached median SALT score 2.4 or less, reflecting almost complete hair regrowth.

64
article thumbnail

A RAVE Upgrade: Previewing Revolutionizing Alopecia Areata, Vitiligo, and Eczema

Dermatology Times

Jonathan Silverberg, MD, PhD, MPH, shares insights into the change of this year’s meeting and the benefit of additional disease states.

Eczema 59
article thumbnail

Serum CXCL10 Levels Decreased With Use of Ruxolitinib Cream In Patients With Vitiligo

Dermatology Times

Data from the TRuE-V mechanism of action study was presented in a poster at the 2024 RAVE Conference.

65
article thumbnail

Oncodermatology: An Emerging Field

Dermatology Times

At the SPDA conference, Meghan Heberton, MD, told attendees about the importance of oncodermatology in patient care.

41
NCEA 2
article thumbnail

What to Expect at the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference

Dermatology Times

The inaugural RAVE conference begins today in Chicago, Illinois.

Eczema 57
article thumbnail

SDPA Membership Ratifies Name Change and Embraces “Associate”

Dermatology Times

SDPA President Laura Bush DMSc, PA-C, DFAAPA, shares exciting news about the name change as the Summer Conference begins to wind down.

36